Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 1,271 | 1,345 | 911 | 397 | 898 |
| Cost of Goods | 652 | 612 | 469 | 203 | 785 |
| Gross Profit | 619 | 733 | 442 | 194 | 113 |
| Operating Expenses | 8,717 | 11,143 | 12,482 | 15,825 | 9,622 |
| Operating Income | -7,446 | -9,798 | -11,571 | -15,428 | -8,724 |
| Other Income | 325 | -3,202 | 65 | 412 | -87 |
| Pre-tax Income | -7,121 | -13,000 | -11,506 | -15,016 | -8,811 |
| Net Income Continuous | -7,121 | -13,000 | -11,506 | -15,016 | -8,811 |
| Net Income | $-7,121 | $-13,000 | $-11,506 | $-15,016 | $-8,811 |
| EPS Basic Total Ops | -0.09 | -0.22 | -0.22 | -0.30 | -0.21 |
| EPS Basic Continuous Ops | -0.09 | -0.22 | -0.22 | -0.30 | -0.21 |
| EPS Diluted Total Ops | -0.09 | -0.22 | -0.22 | -0.30 | -0.21 |
| EPS Diluted Continuous Ops | -0.09 | -0.22 | -0.22 | -0.30 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.22 | -0.22 | -0.19 | -0.21 |
| EBITDA(a) | $-6,828 | $-9,161 | $-10,914 | $-14,777 | $-8,246 |